Xvivo Perfusion AB (publ) XVIVO.ST
Nasdaq Stockholm · Healthcare · Medical Devices
Keep this stock on your watchlist and set email alerts for prices, reports and important announcements where available.
Healthcare on Nasdaq Stockholm
126 stocks in the sector. Xvivo Perfusion ranks 65 of 115.
The sector ranking compares the stocks with each other only: each one's quality, value and momentum scores become its place among the sector's stocks from 0 (worst) to 100 (best), and the ranking is by their average. Sign in to add the upside to the target price to the ranking.
Quality against value
Up is higher quality, right is cheaper. The size of a bubble is the market value.
Sector ranking
The average of the parts, 0 to 100.
All stocks in the sector
| # | Company | Sector score | Quality | Value | Momentum | Upside to target | P/E | ROE | Div. yield | 1 year | Guidance met | Market cap (M) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Sprint Bioscience SPRINT.ST | 94 | 94 | 63 | 90 | 🔒 | 4.6 | 77.0% | 0.0% | +468.2% | – | 422 |
| 2 | Xbrane Biopharma XBRANE.ST | 92 | 94 | 73 | 74 | 🔒 | 2.1 | 22.7% | 0.0% | +20.4% | – | 262 |
| 3 | Nolato NOLA-B.ST | 79 | 71 | 62 | 60 | 🔒 | 17.6 | 14.1% | 3.3% | −13.4% | – | 13,711 |
| 4 | Attendo ATT.ST | 78 | 54 | 51 | 93 | 🔒 | 23.4 | 14.9% | 0.7% | +64.1% | – | 19,062 |
| 5 | Ambea AMBEA.ST | 78 | 51 | 51 | 95 | 🔒 | 23.7 | 12.8% | 1.4% | +56.3% | – | 15,747 |
| 6 | Arjo ARJO-B.ST | 76 | 46 | 60 | 82 | 🔒 | 29.9 | 4.5% | 2.6% | +23.2% | – | 9,991 |
| 7 | Synsam SYNSAM.ST | 75 | 66 | 62 | 57 | 🔒 | 18.4 | 18.6% | 3.1% | −2.5% | – | 8,355 |
| 8 | Saniona SANION.ST | 75 | 95 | 67 | 18 | 🔒 | 5.4 | 44.8% | 0.0% | −31.3% | – | 1,546 |
| 9 | Getinge GETI-B.ST | 75 | 59 | 44 | 88 | 🔒 | 33.5 | 7.7% | 1.7% | +28.5% | – | 75,664 |
| 10 | Arcoma ARCOMA.ST | 74 | 70 | 52 | 66 | 🔒 | 24.2 | 6.7% | 0.0% | +6.2% | – | 122 |
| 11 | CellaVision CEVI.ST | 73 | 84 | 35 | 83 | 🔒 | 31.0 | 17.2% | 1.4% | +14.7% | – | 4,746 |
| 12 | AstraZeneca AZN.ST | 71 | 75 | 38 | 75 | 🔒 | 28.2 | 21.0% | 1.7% | +18.0% | – | 2,851,073 |
| 13 | BioGaia BIOG-B.ST | 70 | 90 | 32 | 75 | 🔒 | 37.1 | 25.3% | 3.3% | +24.8% | – | 12,352 |
| 14 | Cantargia CANTA.ST | 69 | 94 | 71 | 9 | 🔒 | 2.7 | 55.3% | 0.0% | −51.1% | – | 399 |
| 15 | Elekta EKTA-B.ST | 69 | 31 | 47 | 84 | 🔒 | – | −7.3% | 4.0% | +36.5% | – | 23,212 |
| 16 | Mendus IMMU.ST | 69 | – | 59 | 44 | 🔒 | – | −19.4% | 0.0% | −27.6% | – | 328 |
| 17 | RaySearch Laboratories RAY-B.ST | 68 | 82 | 46 | 43 | 🔒 | 26.6 | 23.1% | 2.3% | −17.8% | – | 6,058 |
| 18 | Orexo ORX.ST | 68 | 100 | 77 | 2 | 🔒 | 0.1 | 130.3% | 0.0% | −94.9% | – | 47 |
| 19 | Perpetua Medical PERP-B.ST | 68 | 81 | 81 | 10 | 🔒 | 3.0 | 12.4% | 0.0% | −64.3% | – | 7 |
| 20 | BioArctic BIOA-B.ST | 68 | 91 | 32 | 62 | 🔒 | 26.6 | 52.0% | 0.7% | +8.7% | – | 27,231 |
| 21 | Surgical Science Sweden SUS.ST | 66 | 70 | 41 | 56 | 🔒 | 47.1 | 1.6% | 0.0% | −26.1% | – | 3,146 |
| 22 | Apotea APOTEA.ST | 66 | 69 | 25 | 88 | 🔒 | 47.5 | 27.1% | 0.6% | +30.7% | – | 10,855 |
| 23 | Stille STIL.ST | 65 | 69 | 26 | 83 | 🔒 | 40.9 | 7.9% | 0.0% | +43.6% | – | 2,278 |
| 24 | Moberg Pharma MOB.ST | 65 | 23 | 55 | 73 | 🔒 | – | −4.1% | 0.0% | +33.5% | – | 489 |
| 25 | AddLife ALIF-B.ST | 65 | 56 | 36 | 73 | 🔒 | 40.1 | 10.3% | 0.8% | −6.5% | – | 22,435 |
| 26 | Medicover MCOV-B.ST | 64 | 53 | 33 | 81 | 🔒 | 47.2 | 14.5% | 0.9% | +9.8% | – | 40,311 |
| 27 | Isofol Medical ISOFOL.ST | 63 | – | 28 | 89 | 🔒 | – | −50.2% | 0.0% | +105.8% | – | 397 |
| 28 | Scandinavian Real Heart AB (Publ) HEART.ST | 63 | – | 46 | 58 | 🔒 | – | −56.8% | 0.0% | +11.7% | – | 84 |
| 29 | Carasent CARA.ST | 63 | 71 | 29 | 67 | 🔒 | 50.6 | 4.3% | 0.0% | −6.6% | – | 1,753 |
| 30 | BrainCool BRAIN.ST | 63 | 19 | 37 | 92 | 🔒 | – | −21.1% | 0.0% | +87.1% | – | 423 |
| 31 | Camurus CAMX.ST | 62 | 90 | 14 | 85 | 🔒 | 59.0 | 17.4% | 0.0% | +19.6% | – | 43,422 |
| 32 | Vimian Group VIMIAN.ST | 62 | 56 | 24 | 89 | 🔒 | 64.1 | 4.5% | 0.0% | +40.8% | – | 22,130 |
| 33 | IDL Diagnostics IDLDX.ST | 62 | 28 | 60 | 42 | 🔒 | – | −8.2% | 0.0% | −12.2% | – | 76 |
| 34 | Sectra SECT-B.ST | 61 | 90 | 19 | 80 | 🔒 | 112.0 | 26.4% | 0.7% | +11.3% | – | 63,118 |
| 35 | BICO Group BICO.ST | 61 | 14 | 50 | 80 | 🔒 | – | −62.3% | 0.0% | +1.9% | – | 1,718 |
| 36 | Alvotech ALVO-SDB.ST | 61 | 40 | 36 | 73 | 🔒 | 53.9 | – | 0.0% | +0.0% | – | 14,883 |
| 37 | Bonesupport Holding BONEX.ST | 60 | 84 | 10 | 85 | 🔒 | 148.5 | 16.4% | 0.0% | +53.7% | – | 21,114 |
| 38 | MedCap MCAP.ST | 60 | 75 | 23 | 68 | 🔒 | 38.3 | 15.1% | 0.0% | −3.4% | – | 8,426 |
| 39 | Sedana Medical SEDANA.ST | 59 | 28 | 49 | 52 | 🔒 | – | −6.6% | 0.0% | −5.5% | – | 947 |
| 40 | Vitrolife VITR.ST | 58 | 12 | 56 | 58 | 🔒 | – | −63.5% | 0.9% | −15.2% | – | 16,267 |
| 41 | Vivesto VIVE.ST | 58 | – | 63 | 14 | 🔒 | – | −27.4% | 0.0% | −65.3% | – | 43 |
| 42 | Swedish Orphan Biovitrum SOBI.ST | 56 | 49 | 20 | 89 | 🔒 | 360.3 | 1.3% | 0.0% | +49.9% | – | 172,208 |
| 43 | Bactiguard Holding BACTI-B.ST | 56 | 33 | 37 | 53 | 🔒 | – | −2.5% | 0.0% | −4.3% | – | 543 |
| 44 | Integrum INTEG-B.ST | 56 | 20 | 46 | 53 | 🔒 | – | −26.9% | 0.0% | −3.2% | – | 215 |
| 45 | Flerie FLERIE.ST | 56 | – | 64 | 11 | 🔒 | – | −22.4% | 0.0% | −63.5% | – | 1,133 |
| 46 | Genovis AB (publ.) GENO.ST | 55 | 81 | 17 | 66 | 🔒 | 59.3 | 8.6% | 0.0% | −6.4% | – | 1,394 |
| 47 | Paxman PAX.ST | 55 | 54 | 21 | 77 | 🔒 | – | −4.1% | 0.0% | −5.6% | – | 1,455 |
| 48 | Mentice MNTC.ST | 54 | 49 | 22 | 81 | 🔒 | – | −23.4% | 0.0% | +60.1% | – | 423 |
| 49 | Boule Diagnostics BOUL.ST | 54 | 31 | 69 | 6 | 🔒 | – | −2.2% | 0.0% | −80.9% | – | 47 |
| 50 | C-Rad CRAD-B.ST | 54 | 66 | 33 | 34 | 🔒 | 76.2 | 3.0% | 0.4% | −27.1% | – | 797 |
| 51 | Asker Healthcare Group ASKER.ST | 52 | 46 | 29 | 55 | 🔒 | 59.2 | 7.5% | 0.5% | −14.2% | – | 29,149 |
| 52 | Dynavox Group DYVOX.ST | 52 | 68 | 28 | 40 | 🔒 | 45.1 | 27.5% | 0.7% | −24.7% | – | 7,473 |
| 53 | Nanexa NANEXA.ST | 52 | 50 | 12 | 88 | 🔒 | – | −11.2% | 0.0% | +461.7% | – | 1,616 |
| 54 | ScandiDos SDOS.ST | 52 | 31 | 56 | 14 | 🔒 | – | −8.2% | 0.0% | −52.4% | – | 29 |
| 55 | SenzaGen SENZA.ST | 51 | 26 | 40 | 42 | 🔒 | – | −14.9% | 0.0% | −23.8% | – | 146 |
| 56 | Alzinova ALZ.ST | 51 | – | 64 | 6 | 🔒 | – | −21.5% | 0.0% | −76.6% | – | 36 |
| 57 | Physitrack PTRK.ST | 50 | 12 | 43 | 49 | 🔒 | – | −87.2% | 0.0% | −28.7% | – | 172 |
| 58 | Iconovo ICO.ST | 50 | 10 | 60 | 30 | 🔒 | – | −36.8% | 0.0% | −40.3% | – | 56 |
| 59 | SpectraCure SPEC.ST | 49 | – | 66 | 2 | 🔒 | – | −59.9% | 0.0% | −92.2% | – | 8 |
| 60 | Infant Bacterial Therapeutics IBT-B.ST | 49 | – | 19 | 83 | 🔒 | – | −61.9% | 0.0% | +26.7% | – | 991 |
| 61 | Intervacc IVACC.ST | 49 | 14 | 51 | 32 | 🔒 | – | −29.4% | 0.0% | −19.5% | – | 265 |
| 62 | Ortoma ORT-B.ST | 48 | 25 | 34 | 43 | 🔒 | – | −13.5% | 0.0% | −44.3% | – | 400 |
| 63 | BioInvent International BINV.ST | 48 | 12 | 64 | 10 | 🔒 | – | −59.7% | 0.0% | −92.5% | – | 164 |
| 64 | Neola Medical NEOLA.ST | 48 | – | 60 | 9 | 🔒 | – | −14.5% | 0.0% | −71.4% | – | 39 |
| 65 | Xvivo Perfusion XVIVO.ST | 46 | 62 | 18 | 45 | 🔒 | 247.2 | 1.2% | 0.0% | +11.5% | – | 6,221 |
| 66 | NextCell Pharma NXTCL.ST | 46 | 8 | 58 | 27 | 🔒 | – | −77.8% | 0.0% | −67.3% | – | 31 |
| 67 | Cinclus Pharma Holding CINPHA.ST | 46 | 12 | 43 | 34 | 🔒 | – | −49.8% | 0.0% | −31.1% | – | 562 |
| 68 | Modus Therapeutics Holding MODTX.ST | 45 | – | 38 | 25 | 🔒 | – | −204.4% | 0.0% | −59.3% | – | 19 |
| 69 | Xspray Pharma XSPRAY.ST | 44 | – | 55 | 10 | 🔒 | – | −28.3% | 0.0% | −56.6% | – | 464 |
| 70 | AlzeCure Pharma ALZCUR.ST | 44 | – | 17 | 81 | 🔒 | – | −144.8% | 0.0% | +187.3% | – | 803 |
| 71 | Fluicell FLUI.ST | 44 | 11 | 30 | 66 | 🔒 | – | −76.4% | 0.0% | +118.8% | – | 38 |
| 72 | Enzymatica ENZY.ST | 44 | 15 | 25 | 61 | 🔒 | – | −41.8% | 0.0% | +26.3% | – | 595 |
| 73 | OssDsign OSSD.ST | 43 | 24 | 45 | 13 | 🔒 | – | −16.4% | 0.0% | −66.1% | – | 419 |
| 74 | Active Biotech ACTI.ST | 43 | – | 42 | 16 | 🔒 | – | −67.1% | 0.0% | −44.6% | – | 95 |
| 75 | Promimic PRO.ST | 42 | 26 | 35 | 23 | 🔒 | – | −14.8% | 0.0% | −40.2% | – | 156 |
| 76 | Nosa Plugs NOSA.ST | 42 | 23 | 35 | 26 | 🔒 | – | −19.6% | 0.0% | −41.0% | – | 111 |
| 77 | Senzime SEZI.ST | 42 | 14 | 42 | 23 | 🔒 | – | −45.1% | 0.0% | −40.4% | – | 527 |
| 78 | Q-linea QLINEA.ST | 42 | 9 | 55 | 18 | 🔒 | – | −54.0% | 0.0% | −46.5% | – | 256 |
| 79 | Ascelia Pharma ACE.ST | 42 | – | 56 | 4 | 🔒 | – | −76.7% | 0.0% | −81.9% | – | 71 |
| 80 | Magle Chemoswed Holding MAGLE.ST | 42 | 11 | 66 | 1 | 🔒 | – | −84.0% | 0.0% | −98.5% | – | 6 |
| 81 | S2Medical S2M.ST | 42 | 11 | 61 | 7 | 🔒 | – | −102.2% | 0.0% | −69.0% | – | 4 |
| 82 | Egetis Therapeutics EGTX.ST | 41 | 6 | 18 | 97 | 🔒 | – | −101.2% | 0.0% | +76.2% | – | 4,394 |
| 83 | Devyser Diagnostics DVYSR.ST | 40 | 52 | 24 | 22 | 🔒 | – | −2.4% | 0.0% | −47.7% | – | 1,079 |
| 84 | Biovica International BIOVIC-B.ST | 39 | 8 | 49 | 24 | 🔒 | – | −80.9% | 0.0% | −36.4% | – | 91 |
| 85 | Vicore Pharma Holding VICO.ST | 39 | 9 | 35 | 42 | 🔒 | – | −43.6% | 0.0% | −7.1% | – | 2,877 |
| 86 | Corline Biomedical CLBIO.ST | 39 | 18 | 30 | 29 | 🔒 | – | −15.7% | 0.0% | −34.6% | – | 332 |
| 87 | Episurf Medical EPIS-B.ST | 39 | 6 | 40 | 41 | 🔒 | – | −122.5% | 0.0% | +83.8% | – | 92 |
| 88 | Ortivus ORTI-B.ST | 38 | 15 | 26 | 40 | 🔒 | – | −97.6% | 0.0% | −6.6% | – | 101 |
| 89 | AcouSort ACOU.ST | 38 | 10 | 28 | 49 | 🔒 | – | −74.6% | 0.0% | +11.6% | – | 65 |
| 90 | Initiator Pharma INIT.ST | 38 | – | 30 | 24 | 🔒 | – | −46.3% | 0.0% | −28.5% | – | 149 |
| 91 | Medivir MVIR.ST | 37 | 8 | 30 | 43 | 🔒 | – | −60.8% | 0.0% | +133.5% | – | 538 |
| 92 | EQL Pharma EQL.ST | 36 | 40 | 26 | 13 | 🔒 | 61.1 | 4.7% | 0.0% | −57.7% | – | 766 |
| 93 | Clinical Laserthermia Systems CLS-B.ST | 36 | 11 | 53 | 4 | 🔒 | – | −59.7% | 0.0% | −79.4% | – | 57 |
| 94 | ExpreS2ion Biotech Holding EXPRS2.ST | 36 | 5 | 64 | 2 | 🔒 | – | −106.7% | 0.0% | −94.4% | – | 9 |
| 95 | Spago Nanomedical SPAGO.ST | 35 | 5 | 54 | 13 | 🔒 | – | −86.4% | 0.0% | −75.1% | – | 24 |
| 96 | SynAct Pharma SYNACT.ST | 34 | – | 25 | 32 | 🔒 | – | −65.1% | 0.0% | −33.3% | – | 815 |
| 97 | IRLAB Therapeutics IRLAB-A.ST | 33 | 5 | 23 | 66 | 🔒 | – | −358.1% | 0.0% | −14.9% | – | 178 |
| 98 | Cereno Scientific CRNO-B.ST | 32 | – | 39 | 7 | 🔒 | – | −46.6% | 0.0% | −77.9% | – | 507 |
| 99 | Annexin Pharmaceuticals ANNX.ST | 32 | – | 35 | 10 | 🔒 | – | −148.0% | 0.0% | −66.5% | – | 64 |
| 100 | Immunovia IMMNOV.ST | 32 | 1 | 62 | 3 | 🔒 | – | −225.3% | 0.0% | −88.0% | – | 25 |
| 101 | Nanologica NICA.ST | 32 | 5 | 57 | 3 | 🔒 | – | −226.5% | 0.0% | −86.9% | – | 15 |
| 102 | FluoGuide FLUO.ST | 32 | – | 22 | 34 | 🔒 | – | −72.4% | 0.0% | −27.3% | – | 497 |
| 103 | Ortivus ORTI-A.ST | 31 | 15 | 22 | 26 | 🔒 | – | −97.6% | 0.0% | −34.5% | – | 148 |
| 104 | Pila Pharma PILA.ST | 31 | 5 | 26 | 47 | 🔒 | – | −116.1% | 0.0% | −27.0% | – | 67 |
| 105 | Prostatype Genomics PROGEN.ST | 29 | 2 | 58 | 2 | 🔒 | – | −167.8% | 0.0% | −83.0% | – | 15 |
| 106 | Dicot Pharma DICOT.ST | 24 | – | 22 | 19 | 🔒 | – | −109.4% | 0.0% | −53.5% | – | 477 |
| 107 | Elicera Therapeutics ELIC.ST | 23 | – | 23 | 14 | 🔒 | – | −74.5% | 0.0% | −57.4% | – | 130 |
| 108 | Acarix ACARIX.ST | 22 | 5 | 24 | 23 | 🔒 | – | −126.0% | 0.0% | −37.8% | – | 193 |
| 109 | Alligator Bioscience ATORX.ST | 22 | 1 | 48 | 0 | 🔒 | – | −748.7% | 0.0% | −99.5% | – | 7 |
| 110 | OncoZenge ONCOZ.ST | 20 | 4 | 25 | 16 | 🔒 | – | −188.0% | 0.0% | −39.9% | – | 40 |
| 111 | Neem's Hill NEEMS-B.ST | 16 | 9 | 17 | 13 | 🔒 | – | −252.9% | 0.0% | −61.6% | – | 55 |
| 112 | iZafe Group IZAFE-B.ST | 15 | 6 | 21 | 11 | 🔒 | – | −142.7% | 0.0% | −67.3% | – | 83 |
| 113 | Gabather GABA.ST | 15 | – | 18 | 13 | 🔒 | – | −702.7% | 0.0% | −49.0% | – | 9 |
| 114 | Luxbright LXB.ST | 12 | 10 | 16 | 3 | 🔒 | – | −72.4% | 0.0% | −90.6% | – | 893 |
| 115 | SciBase Holding SCIB.ST | 11 | 5 | 20 | 9 | 🔒 | – | −1,307.8% | 0.0% | −56.1% | – | 58 |
| – | Hansa Biopharma HNSA.ST | – | – | – | 74 | 🔒 | – | – | 0.0% | +29.8% | – | 3,936 |
| – | Oncopeptides ONCO.ST | – | – | – | 23 | 🔒 | – | – | 0.0% | −69.9% | – | 478 |
| – | Klaria Pharma Holding AB (publ.) KLAR.ST | – | – | – | 33 | 🔒 | – | – | 0.0% | +1.8% | – | 129 |
| – | Xintela XINT.ST | – | – | – | 11 | 🔒 | – | – | 0.0% | −66.5% | – | 118 |
| – | Simris Group AB (PUBL) SIMRIS-B.ST | – | – | – | 66 | 🔒 | – | – | 0.0% | +26.6% | – | 98 |
| – | Enorama Pharma ERMA.ST | – | – | – | 36 | 🔒 | – | – | 0.0% | −70.9% | – | 60 |
| – | Disruptive Pharma DPHA.ST | – | – | – | – | 🔒 | – | – | 0.0% | – | – | 43 |
| – | Aino Health AINO.ST | – | – | – | 66 | 🔒 | – | – | 0.0% | +6.4% | – | 37 |
| – | Qlife Holding QLIFE.ST | – | – | – | 16 | 🔒 | – | – | 0.0% | −55.3% | – | 15 |
| – | Diamyd Medical DMYD-B.ST | – | – | – | 2 | 🔒 | – | −60.6% | 0.0% | −90.6% | – | – |
| – | Newbury Pharmaceuticals NEWBRY.ST | – | – | – | 42 | 🔒 | – | – | 0.0% | −24.1% | – | – |
Click a heading to sort. Market cap in millions of SEK. Not investment advice. Compare the share prices →
Not investment advice. Figures may contain errors from the data source.